Clinical Associate Professor, Department of Obstetrics and Gynecology
Clinical Associate Professor, Department of Medical Ethics, Humanities, and Law
Biosketch
David Shalowitz, MD, MSHP attended medical school at the University of Michigan and residency in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals. He then received subspecialty training in gynecologic oncology and a master’s degree in health policy research from the University of Pennsylvania. Dr. Shalowitz also completed a fellowship in clinical bioethics at the National Institutes of Health. Dr. Shalowitz is a nationally-recognized researcher in health equity and access to gynecologic cancer care, and brings this background to his role as Director for Health Equity and Community Outreach at West Michigan Cancer Center. He is particularly invested in helping patients who live in rural areas in the United States overcome barriers to receiving high-quality cancer care, and is privileged to focus his efforts on patients treated in southwestern Michigan. Dr. Shalowitz is also an accomplished bioethicist, and has served on multiple organizations' ethics committees, including as Chair of the Committee on Ethics for the American College of Obstetricians and Gynecologists. He is widely published and cited in the peer-reviewed literature and focuses his research on the intersection between ethics and health policy related to access to cancer care.
-
Education and Training
- MS 2017, Health Policy Research, University of Pennsylvania
- Fellowship 2017, Gynecologic Oncology, University of Pennsylvania Health System
- Residency 2014, Obstetrics and Gynecology, Brigham and Women's/Massachusetts General Hospital, Harvard Medical School
- MD 2010, Medicine, Medical School, University of Michigan
- Fellowship 2005, Clinical Bioethics, National Institutes of Health
- AB 2003, Religious Studies, Biology, Brown University
-
Research
- Rural Health
- Health Equity
- Gynecological cancers
- Biomedical Ethics
- Access to care
-
Publications
Saylor K.W., Fernandes E.Q., Adams M., Paraghamian S., Shalowitz D.I. Predictors of germline genetic testing referral and completion in ovarian cancer patients at a Comprehensive Cancer Center Gynecologic Oncology. 2024;186:53-60.
Shalowitz D.I., Miller F.G. Are Patients with Cancer Best Managed in a Clinical Trial? JAMA. 2024;331:2077-2078.
Shalowitz D.I., Rajczi A. Refining research on access to gynecologic cancer care: The DIMeS framework Gynecologic Oncology. 2024;188:158-161.
Wagi C., Shalowitz D.I., Randazzo A., Peluso A., Birken S. Physician perspectives on clinician-to-clinician telemedical consultation for gynecologic cancers: A qualitative study Gynecologic Oncology Reports. 2024;52
Arora K.S., Shalowitz D.I., Kislovskiy Y. Ethical Considerations for the Delivery of Obstetric and Gynecologic Care During a Pandemic: ACOG Committee Statement No. 6 Obstetrics and Gynecology. 2023;142:225-230.
DeMari J.A., Dressler E.V., Foraker R.E., Wells B.J., Smith S., Klepin H., Hundley W.G., Lesser G.J., Shalowitz D.I., Nightingale C.L., Hernandez M., Weaver K.E. Endometrial cancer survivors' perceptions of their cardiovascular disease risk (results from WF-1804CD AH-HA) Gynecologic Oncology. 2023;174:208-212.
Shalowitz D.I., Arkwright B., Bunce E.E. Determining the Value-on-Investment of Provider-to-Provider Vir tual Consultation for Cancer Care Telehealth and Medicine Today. 2023;8
Shalowitz D.I., Hung P., Zahnd W.E., Eberth J. Pre-pandemic geographic access to hospital-based telehealth for cancer care in the United States PLoS ONE. 2023;18(1 January)
Shalowitz D.I., Magalhaes M., Miller F.G. Ethical Outreach for Rural Cancer Care in the United States: Balancing Access With Optimal Clinical Outcomes JCO Oncology Practice. 2023;19:225-229.
Shalowitz D.I., Ralston S.J. Safeguards for procedural consent in obstetric care Journal of Medical Ethics. 2023
Shalowitz D.I., Schroeder M.C., Birken S.A. An implementation science approach to the systematic study of access to gynecologic cancer care Gynecologic Oncology. 2023;172:78-81.
Sohl S.J., Tooze J.A., Levine B.J., Zeidan F., Wheeler A., Kelly M., Shalowitz D., Danhauer S.C. A randomized pilot of eHealth mindful movement and breathing to improve gynecologic surgery outcomes Journal of Psychosocial Oncology. 2023;41:251-266.
DeMari J.A., Shalowitz D.I. Routine informed consent for mismatch repair testing in endometrial cancers: Review and ethical analysis Gynecologic Oncology. 2022;167(1):123-128.
Kraus E.J., Nicosia B., Shalowitz D.I. A qualitative study of patients' attitudes towards telemedicine for gynecologic cancer care Gynecologic Oncology. 2022;165(1):155-159.
Shalowitz D.I., Charlton M.E. The road to geographic equity in access to gynecologic cancer care Gynecologic Oncology. 2022;166(3):375-376.
Shalowitz D.I., DeMari J.A. Defining the essential role of the gynecologic oncologist in rural ovarian cancer care delivery Gynecologic Oncology. 2022;164(1):1-2.
Shalowitz D.I., Tucker-Edmonds B., Marshall M.F., White A. Responding to patient requests for women obstetrician-gynecologists American Journal of Obstetrics and Gynecology. 2022;226(5):678-682.
Bruno B., Shalowitz D.I., Arora K.S. Ethical challenges for women's healthcare highlighted by the COVID-19 pandemic Journal of Medical Ethics. 2021;47(2):69-72.
Moore C.J., Shalowitz D.I. State Standards for Insurance Access to Oncologists JNCI Cancer Spectrum. 2021;5(1)
Mujumdar V., Butler T.R., Shalowitz D.I. A qualitative study on the impact of long-distance travel for gynecologic cancer care Gynecologic Oncology Reports. 2021;38
Shalowitz D.I. Physician outreach and access to gynecologic cancer care Gynecologic Oncology. 2021;160(1):1-2.
Laventhal N., Basak R., Dell M.L., Diekema D., Elster N., Geis G., Mercurio M., Opel D., Shalowitz D., Statter M., MacAuley R. The ethics of creating a resource allocation strategy during the COVID-19 Pandemic Pediatrics. 2020;146(1)
Laventhal N.T., Basak R.B., Dell M.L., Elster N., Geis G., Macauley R.C., Mercurio M.R., Opel D.J., Shalowitz D.I., Statter M.B., Diekema D.S. Professional Obligations of Clinicians and Institutions in Pediatric Care Settings during a Public Health Crisis: A Review Journal of Pediatrics. 2020;224:10-15.
Shalowitz D.I., Anderson T.L. Safeguarding Against Sexual Misconduct Obstetrics and Gynecology. 2020;135(1):6-8.
Shalowitz D.I., Lefkowits C., Landrum L.M., von Gruenigen V.E., Spillman M.A. Principles of ethics and critical communication during the COVID-19 pandemic Gynecologic Oncology. 2020;158(3):526-530.
Shalowitz D.I., Moore C.J. Telemedicine and Gynecologic Cancer Care Obstetrics and Gynecology Clinics of North America. 2020;47(2):271-285.
Shalowitz D.I., Goodwin A., Schoenbachler N. Does surgical treatment of atypical endometrial hyperplasia require referral to a gynecologic oncologist? American Journal of Obstetrics and Gynecology. 2019;220(5):460-464.
Sohl S.J., Tooze J.A., Wheeler A., Zeidan F., Wagner L.I., Evans S., Kelly M., Shalowitz D., Green M., Levine B., Danhauer S.C. Iterative adaptation process for eHealth Mindful Movement and Breathing to improve gynecologic cancer surgery outcomes Psycho-Oncology. 2019;28(8):1774-1777.
Shalowitz D., Cohn D. Cancer care delivery research in gynecologic oncology Gynecologic Oncology. 2018;148(3):445-448.
Shalowitz D.I., Huh W.K. Access to gynecologic oncology care and the network adequacy standard Cancer. 2018;124(13):2677-2679.
Shalowitz D.I., Nivasch E., Burger R.A., Schapira M.M. Are Patients Willing to Travel for Better Ovarian Cancer Care? Obstetrical and Gynecological Survey. 2018;73(3):152-153.
Shalowitz D.I., Nivasch E., Burger R.A., Schapira M.M. Are patients willing to travel for better ovarian cancer care? Gynecologic Oncology. 2018;148(1):42-48.
Venigalla S., Chowdhry A., Shalowitz D. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers Gynecologic Oncology. 2018;149(3):531-538.
Shalowitz D.I. Commercial Enterprises in Medical Practice Obstetrics and Gynecology. 2017;130(2):484-485.
Shalowitz D.I. Commercial Enterprises in Medical Practice Obstetrics and Gynecology. 2017;130(2):E71-E73.
Shalowitz D.I., Epstein A.J., Buckingham L., Ko E.M., Giuntoli R.L. Survival Implications of Time to Surgical Treatment of Endometrial Cancers Obstetrical and Gynecological Survey. 2017;72(4):228-230.
Shalowitz D.I., Epstein A.J., Buckingham L., Ko E.M., Giuntoli R.L. Survival implications of time to surgical treatment of endometrial cancers American Journal of Obstetrics and Gynecology. 2017;216(3):268.e1-268.e18.
Dean L.T., Zhang X., Latif N., Giuntoli R., Lin L., Haggerty A., Kim S., Shalowitz D., Stashwick C., Simpkins F., Burger R., Morgan M., Ko E., Schmitz K. Race-based disparities in loss of functional independence after hysterectomy for uterine cancer Supportive Care in Cancer. 2016;24(8):3573-3580.
Shalowitz D., Epstein A., Ko E., Giuntoli R. Non-surgical management of ovarian cancer: Prevalence and implications Gynecologic Oncology. 2016;142(1):30-37.
Shalowitz D., Spillman M., Morgan M. Interactions with industry under the Sunshine Act: An example from gynecologic oncology American Journal of Obstetrics and Gynecology. 2016;214(6):703-707.
Shalowitz D., Spillman M., Morgan M. Reply American Journal of Obstetrics and Gynecology. 2016;215(6):811.
Shalowitz D., Vinograd A., Giuntoli R. Geographic Access to Gynecologic Cancer Care in the United States Obstetrical and Gynecological Survey. 2015;70(12):754-755.
Shalowitz D.I., Schorge J.O. Suggestibility of oncologists' clinical estimates JAMA Oncology. 2015;1(2):251-253.
Shalowitz D.I., Smith A.G., Bell M.C., Gibb R.K. Teleoncology for gynecologic cancers Gynecologic Oncology. 2015;139(1):172-177.
Shalowitz D.I., Vinograd A.M., Giuntoli R.L. Geographic access to gynecologic cancer care in the United States Gynecologic Oncology. 2015;138(1):115-120.
Shalowitz D., Rauh-Hain J., Oyekan J., Cohen S. Laparoscopic salpingo-oophorectomy for ovarian torsion in the third trimester Gynecological Surgery. 2013;10(2):151-153.
Winkelman W., Shalowitz D. Typical-Use Contraception and Pharmaceutical Research American Journal of Bioethics. 2012;12(7):42-43.
Christensen K.D., Roberts J.S., Shalowitz D.I., Everett J.N., Kim S.Y.H., Raskin L., Gruber S.B. Disclosing individual CDKN2A research results to melanoma survivors: Interest, impact, and demands on researchers Cancer Epidemiology Biomarkers and Prevention. 2011;20(3):522-529.
Shalowitz D., Ecker J. Research in Pregnancy: Back to first Principles American Journal of Bioethics. 2011;11(5):56-57.
Roberts J.S., Shalowitz D.I., Christensen K.D., Everett J.N., Kim S.Y.H., Raskin L., Gruber S.B. Returning individual research results: Development of a cancer genetics education and risk communication protocol Journal of Empirical Research on Human Research Ethics. 2010;5(3):17-30.
Shalowitz D., Silveira M. Building a better advance directive: Next steps American Journal of Bioethics. 2010;10(4):34-36.
Shalowitz D.I., Barnosky A., Smith L.B. Ethical analysis of communicating the risk of iatrogenic creutzfeldt-jakob disease Infection Control and Hospital Epidemiology. 2009;30(8):805-806.
Housri N., Weil R.J., Shalowitz D.I., Koniaris L.G. Should informed consent for cancer treatment include a discussion about hospital outcome disparities? PLoS Medicine. 2008;5(10):1413-1417.
Shalowitz D., Miller F. Communicating the results of clinical research to participants: Attitudes, practices, and future directions PLoS Medicine. 2008;5(5):0714-0720.
Shalowitz D., Miller F. The search for clarity in communicating research results to study participants Journal of Medical Ethics. 2008;34(9)
Shalowitz D., Garrett-Mayer E., Wendler D. How should treatment decisions be made for incapacitated patients, and why? PLoS Medicine. 2007;4(3):423-428.
Wendler D., Shalowitz D. Correction: Health Insurance Portability and Accountability Act privacy rule and research consent documents (Annals of Internal Medicine) (2006) 145 (790)) Annals of Internal Medicine. 2007;146(3):232.
Shalowitz D., Garrett-Mayer E., Wendler D. The accuracy of surrogate decision makers: A systematic review Archives of Internal Medicine. 2006;166(5):493-497.
Shalowitz D., Wendler D. Informed consent for research and authorization under the health insurance portability and accountability act privacy rule: An integrated approach Annals of Internal Medicine. 2006;144(9):685-688.
Shalowitz D.I., Miller F.G. Implications of disclosing individual results of clinical research [10] JAMA. 2006;295(1):37-38.
Wendler D., Shalowitz D. In response Annals of Internal Medicine. 2006;145(10):790-791.
Shalowitz D.I., Miller F.G. Disclosing individual results of clinical research: Implications of respect for participants JAMA. 2005;294(6):737-740.
Shalowitz D., Emanuel E. Euthanasia and physician-assisted suicide: Implications for physicians Journal of Clinical Ethics. 2004;15(3):232-236.
Shalowitz D., Wolf M. Shared decision-making and the lower literate patient Journal of Law, Medicine and Ethics. 2004;32(4):759-764.